Thalassaemia (part 2): Management

N A Alli; M Patel; J Poole; Y Goga; F Fazel; N Novitzky; S Parasnath; F Bassa

Continuing Medical Education

Thalassaemia (part 2): Management

N A Alli, M Patel, J Poole, Y Goga, F Fazel, N Novitzky, S Parasnath, F Bassa

Abstract

Authors' affiliations

N A Alli, Department of Molecular Medicine and Haematology, Faculty of Health Sciences, University of the Witwatersrand and National Health Laboratory Service, Johannesburg, South Africa

M Patel, Department of Medicine, Chris Hani Baragwanath Academic Hospital and Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa

J Poole, Department of Paediatrics and Child Health, Paediatric Haematology/Oncology Unit, Faculty of Health Sciences, University of the Witwatersrand and Charlotte Maxeke Hospital, Johannesburg, South Africa

Y Goga, Department of Paediatrics and Child Health, Nelson R Mandela School of Medicine, University of KwaZulu-Natal and Inkosi Albert Luthuli Central Hospital, Durban, South Africa

F Fazel, Blood Centre, Rondebosch Medical Centre, Cape Town, South Africa

N Novitzky, Division of Clinical Haematology, Department of Internal Medicine, Faculty of Medicine and Health Sciences, Tygerberg Academic Hospital and Stellenbosch University, Cape Town, South Africa

S Parasnath, Department of Clinical Haematology, Inkosi Albert Luthuli Central Hospital and Nelson R Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa

F Bassa, Division of Clinical Haematology, Department of Internal Medicine, Faculty of Medicine and Health Sciences, Tygerberg Academic Hospital and Stellenbosch University, Cape Town, South Africa